Alpelisib
- Status:
- Do Not Prescribe (DNP), Red
- Decision Date:
- November 2020
Comments
RED
- Advanced or metastatic breast cancer. NHSE
commissioned. (Decision date - November 2020).
- NICE TA816 - Alpelisib with fulvestrant for
treating hormone-receptor positive, HER2-negative, PIK3CA-positive advanced
breast cancer. (Decision date - September 2022).
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again